Protein kinase G II-mediated proliferative effects in human cultured prostatic stromal cells
- PMID: 14636895
- DOI: 10.1016/s0898-6568(03)00134-7
Protein kinase G II-mediated proliferative effects in human cultured prostatic stromal cells
Abstract
This study investigates the effect of protein kinase G (PKG) activation upon proliferation of human cultured prostatic stromal cells. The PKG II activator (8-pCPT-cGMP; IC50 of 113+/-42 nM) and the phosphodiesterase inhibitor, zaprinast (up to 50 microM), but not the PKG I isoform activators (APT-cGMP and PET-cGMP), reduced foetal calf serum-stimulated proliferation. The effect of 8-pCPT-cGMP (30 microM) was blocked by Rp-8-Br-cGMPS (5 microM) and Rp-8-pCPT-cGMP (5 microM), but not Rp-cAMPS (5 microM). 8-pCPT-cGMP (30 microM) and zaprinast (50 microM), but not PET-cGMP (30 microM), caused a significant increase in atypical nuclei and an increase in annexin-V staining. These data indicate that activation of PKG II induces apoptosis of human cultured prostatic stromal cells.
Similar articles
-
Effect of four cGMP analogues with different mechanisms of action on hormone release by porcine ovarian granulosa cells in vitro.Exp Clin Endocrinol Diabetes. 2000;108(3):214-9. doi: 10.1055/s-2000-7745. Exp Clin Endocrinol Diabetes. 2000. PMID: 10926319
-
Effect of cGMP analogues and protein kinase G blocker on secretory activity, apoptosis and the cAMP/protein kinase A system in porcine ovarian granulosa cells in vitro.J Steroid Biochem Mol Biol. 2000 Sep;74(1-2):1-9. doi: 10.1016/s0960-0760(00)00082-0. J Steroid Biochem Mol Biol. 2000. PMID: 11074350
-
Inhibition of cGMP-dependent protein kinase by the cell-permeable peptide DT-2 reveals a novel mechanism of vasoregulation.Mol Pharmacol. 2004 May;65(5):1111-9. doi: 10.1124/mol.65.5.1111. Mol Pharmacol. 2004. PMID: 15102939
-
(Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor.Eur J Pharmacol. 1994 Oct 14;269(2):265-8. doi: 10.1016/0922-4106(94)90095-7. Eur J Pharmacol. 1994. PMID: 7851503
-
Protein kinase G activation of K(ATP) channels in human-cultured prostatic stromal cells.Cell Signal. 2002 Dec;14(12):1023-9. doi: 10.1016/s0898-6568(02)00050-5. Cell Signal. 2002. PMID: 12359308
Cited by
-
Type II cGMP-dependent protein kinase inhibits activation of key members of the RTK family in gastric cancer cells.Biomed Rep. 2013 May;1(3):399-404. doi: 10.3892/br.2013.85. Epub 2013 Mar 21. Biomed Rep. 2013. PMID: 24648957 Free PMC article.
-
The new horizons of pharmacotherapy. Unexpected pharmacological actions and a new therapeutic strategy of phosphodiesterase-5 inhibitors.Cent European J Urol. 2014;67(3):314-8. doi: 10.5173/ceju.2014.03.art20. Epub 2014 Aug 18. Cent European J Urol. 2014. PMID: 25247094 Free PMC article. Review.
-
Endogenous cGMP-dependent protein kinase reverses EGF-induced MAPK/ERK signal transduction through phosphorylation of VASP at Ser239.Oncol Lett. 2012 Nov;4(5):1104-1108. doi: 10.3892/ol.2012.851. Epub 2012 Aug 6. Oncol Lett. 2012. PMID: 23162660 Free PMC article.
-
Uroflowmetric assessment of acute effects of sildenafil on the voiding of men with erectile dysfunction and symptomatic benign prostatic hyperplasia.Int Urol Nephrol. 2009;41(2):287-92. doi: 10.1007/s11255-008-9423-y. Epub 2008 Jul 22. Int Urol Nephrol. 2009. PMID: 18649004 Clinical Trial.
-
Type II cyclic guanosine monophosphate-dependent protein kinase inhibits epidermal growth factor receptor activation in different cancer cell lines.Oncol Lett. 2015 Jun;9(6):2781-2786. doi: 10.3892/ol.2015.3067. Epub 2015 Mar 23. Oncol Lett. 2015. PMID: 26137146 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources